Biogen Idec

Makers of the 10 Top-Selling Cancer Drugs Catch the Eye of Analyst
24/7 Wall St
Thu, 10/2/14 - 09:34 am
Celgene
Novartis
Eli Lilly
JNJ
Bristol-Myers Squibb
Biogen Idec
Biogen shoulders into gene therapy amid a second honeymoon for the field
Fierce Biotech
Wed, 09/24/14 - 08:42 am
Biogen Idec
gene therapy
Big Pharma: $100 Billion In Future Sales Expected
Bidness Etc.
Mon, 09/15/14 - 10:10 am
Bristol-Myers Squibb
Merck
GSK
Novo Nordisk
Sanofi
Novartis
Pfizer
Biogen Idec
Roche
Biogen Shows Positive Effects in Year Two of RMS Drug Trial
Drug Discovery and Development
Fri, 09/12/14 - 08:47 am
Biogen Idec
Plegridy
RMS
Biogen Idec Inc Suddenly Struggling To Keep Up With The Biotech Joneses
Yahoo/Benzinga
Thu, 09/11/14 - 10:25 am
Biogen Idec
Biogen Idec: Drug Approval Offers ‘Underappreciated Earnings Upside,” Morgan Stanley Says
Barron's
Mon, 08/18/14 - 11:52 am
earnings
Biogen Idec
MS
multiple sclerosis
Plegridy
Forward Pharma sets sights on Biogen with a $200M IPO
Fierce Biotech
Mon, 08/11/14 - 11:55 am
Forward Pharma
Biogen Idec
IPOs
FP187
MS
multiple sclerosis
Biogen Idec (BIIB) Stock Spikes Following Second Quarter Earnings Beat
TheStreet.com
Wed, 07/23/14 - 10:39 am
earnings
Biogen Idec
Top Biotech Earnings Previews for the Week Ahead
24/7 Wall St
Mon, 07/21/14 - 09:20 am
earnings
Cubist Pharma
Gilead Sciences
Biogen Idec
Celgene
Illumina
Alexion
Biogen prices new, long-acting hemophilia med with eye on patient-switching
Fierce Pharma Marketing
Wed, 07/9/14 - 05:15 pm
Biogen Idec
hemophilia
patient-switching
Alprolix
Is this Biogen's Biggest Risk?
Motley Fool
Tue, 07/1/14 - 11:54 pm
Biogen Idec
Tecfidera
MS
multiple sclerosis
Biogen Hemophilia Drugs Launch Into The Unknown
Investors.com
Mon, 06/30/14 - 05:53 pm
Biogen Idec
hemophilia
Alprolix
Eloctate
Biogen Idec Has Lagged Its Biotech Peers, Now Is The Time To Shine!
Seeking Alpha
Thu, 06/26/14 - 12:48 pm
Biogen Idec
Expecting hostile suitors, Shire brings in reinforcements
Fierce Pharma
Wed, 06/18/14 - 05:31 am
Shire
M&A
Bristol-Myers Squibb
Amgen
AbbVie
Gilead Sciences
Biogen Idec
Biogen, AbbVie drug slows MS episodes, safety issues recur
Yahoo/Reuters
Mon, 06/16/14 - 08:35 pm
AbbVie
Biogen Idec
MS
multiple sclerosis
daclizumab
What Will Happen When Biotech Drugs Go Generic?
Forbes
Fri, 06/13/14 - 10:58 am
biotech
generics
Amgen
Roche
Biogen Idec
Eli Lilly
Bristol-Myers Squibb
Sanofi
Novartis
Sandoz
Omnitrope
Genotropin
This Week in Biotech: A Trifecta of Disappointment Mars ASCO While Biogen Scores a Big Victory
Motley Fool
Mon, 06/9/14 - 09:17 am
ASCO
Biogen Idec
Elocate
neratinib
Puma Biotechnology
CO-1686
Clovis Oncology
Tykerb
GSK
Roche
FDA approves Biogen's hemophilia A drug Eloctate
Yahoo/Reuters
Fri, 06/6/14 - 05:22 pm
FDA
Biogen Idec
hemophilia A
Eloctate
Biogen shares could rise 20% on robust drug pipeline, Barron's contends
The Fly on the Wall
Fri, 05/23/14 - 06:58 am
Biogen Idec
Tysabri
Avonex
Tecfidera
Eloctate
Alprolix
Catalyst For Perrigo: Sale Of Tysabri Royalties
Seeking Alpha
Thu, 05/22/14 - 11:55 am
Perrigo
Tysabri
Biogen Idec

Pages